Midmark Diagnostics recognised for leadership in patient monitoring
6 April, 2005
PALO ALTO, Calif. USA. Frost & Sullivan has named Midmark Diagnostics
Group as the recipient of the 2005 Competitive Strategy Leadership of the
Year Award for its innovative and trend-setting strategies that have enabled
the company to gain a competitive edge over its peers in the patient
monitoring diagnostic devices industry.
With rising costs, staff shortages, and escalating patient volumes, the
ability to accurately and efficiently facilitate patient-centric information
has become increasingly challenging. Midmark Diagnostics is using its
operational strategy to close the gap between such information disparities.
"Midmark not only strives to consistently improve device quality but also
pursues partnership strategies for value-added clinical integration, which
removes the communication barriers among clinicians and improves
departmental workflow," says Frost & Sullivan industry manager Vivek
Partnering with over 80 electronic medical record (EMR) vendors, Midmark
moves beyond interfacing and places greater emphasis on the ability to
integrate and facilitate information transfer on a continual basis. Such a
strategy has enabled the company to remain several notches above its peers
in the patient monitoring diagnostics devices industry.
"We are thrilled to be recognized by a world-renowned and prestigious
organization such as Frost & Sullivan," said George Stickel, president of
Midmark Diagnostics. "This award adds independent accreditation to our
already strong belief that efficient diagnostic devices must be able to
seamlessly integrate into the electronic medical record."
In order to achieve seamless and easy-to-use information flow, Midmark
embeds its diagnostic measurement devices directly into the partners'
inpatient/outpatient EMR applications.
"In one such partnership, Midmark embedded its diagnostic devices with
Misys Healthcare Systems' EMR solution, enabling physicians to view and
diagnose results from Spirometers, Holter tests, and ECG with minimal
difficulty," observes Subramany.
In the future, PC-based ECG is expected to become extremely popular as
hospitals and clinicians turn to one-source capabilities for data
"In this regard, Midmark is poised for success as its key value
proposition is the ability to access data at a single source, rather than
switching between disparate multi-party systems," says Subramany. "This not
only saves time, labour, and costs, but will also substantially enhance the
quality of patient care delivery."
Frost & Sullivan presents this award to the company that leverages its
competitive strategy to increase market share and move to the forefront of
its industry. The award recipient also utilises market changes to introduce
new and unique methods of capturing and strengthening market presence.